Holen Sie sich die Stockscreener-App
200.96
1.04%
-2.12
Handel nachbörslich:
201.56
0.60
+0.30%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$203.08
Offen:
$202.865
24-Stunden-Volumen:
12.75M
Relative Volume:
1.16
Marktkapitalisierung:
$252.41B
Einnahmen:
$19.59B
Nettoeinkommen (Verlust:
$5.81B
KGV:
44.28
EPS:
4.538
Netto-Cashflow:
$5.55B
1W Leistung:
+17.40%
1M Leistung:
+23.49%
6M Leistung:
+101.30%
1J Leistung:
+160.85%
1-Tages-Spanne:
$195.04
$203.22
1-Wochen-Bereich:
$177.50
$210.45
52-Wochen-Spanne:
$56.32
$210.45
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Vergleichen Sie LRCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
200.96 | 255.07B | 19.59B | 5.81B | 5.55B | 4.538 |
|
ASML
Asml Holding Nv
|
1,194.32 | 476.83B | 35.54B | 10.43B | 9.71B | 26.71 |
|
AMAT
Applied Materials Inc
|
281.64 | 231.70B | 28.37B | 7.00B | 5.70B | 8.6741 |
|
KLAC
Kla Corp
|
1,324.60 | 178.65B | 12.52B | 4.24B | 3.87B | 31.85 |
|
TER
Teradyne Inc
|
216.31 | 34.84B | 2.86B | 443.08M | 456.83M | 2.7476 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Applied Materials, KLA Corporation, Lam Research, Seagate Technology, and Western Digital Stocks Trade Down, What You Need To Know - Barchart.com
WD Rutherford LLC Acquires New Holdings in Lam Research Corporation $LRCX - MarketBeat
Jim Cramer Notes That Lam Research Is One of the Stocks He Likes "So Much" - Finviz
Jim Cramer Notes That Lam Research Is One of the Stocks He Likes “So Much” - Insider Monkey
9,465 Shares in Lam Research Corporation $LRCX Bought by Realta Investment Advisors - MarketBeat
Lam Research Corporation Announces December Quarter Financial Conference Call - Finviz
Lam Research Corporation Announces December Quarter Financial Co - GuruFocus
Want to hear Lam Research’s financial call? Here’s when to tune in - Stock Titan
Lam Research Corporation Stock (LRCX) Opinions on Recent 'Buy' Rating and AI Demand - Quiver Quantitative
Lam Research stock slips after two-day rally as traders weigh fresh Buy call and CES headlines - TechStock²
SkyOak Wealth LLC Invests $864,000 in Lam Research Corporation $LRCX - MarketBeat
Securian Asset Management Inc. Lowers Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
First Merchants Corp Trims Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Bought by Childress Capital Advisors LLC - MarketBeat
Lam Research, Micron Tech among market cap stock movers on Tuesday - Investing.com
Lam Research (NASDAQ:LRCX) Shares Up 6.3%What's Next? - MarketBeat
Lam Research Corp Is Printing the Future of AI Chips – But Is LRCX Still Worth the Hype? - AD HOC NEWS
Lam Research stock jumps 6% after Aletheia starts coverage with $260 target - TechStock²
Why Lam Research (LRCX) Stock Is Trading Up Today - Finviz
Micron and Lam Research among market cap stock movers on Tuesday - Investing.com Australia
Lam Research stock initiated with Buy rating at Aletheia Capital - Investing.com
Hennion & Walsh Asset Management Inc. Buys 7,392 Shares of Lam Research Corporation $LRCX - MarketBeat
Robeco Institutional Asset Management B.V. Has $259 Million Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Is Lam Research (LRCX) Still Attractive After A 153% One Year Share Price Surge - Yahoo Finance
What's Driving the Market Sentiment Around Lam Research Corp? - Benzinga
6 Newly Overvalued Stocks this Week - Morningstar
Lam Research Options Trading: A Deep Dive into Market Sentiment - Benzinga
Lam Research Corporation $LRCX is Harbor Island Capital LLC's Largest Position - MarketBeat
CWA Asset Management Group LLC Purchases 22,171 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research stock hits a record close after Citi spotlight — what LRCX investors watch next - TechStock²
Lam Research's (NASDAQ:LRCX) three-year earnings growth trails the fantastic shareholder returns - simplywall.st
Lam Research stock jumps 8% to start 2026 as chip-tool shares rally — what LRCX investors watch next - TechStock²
GAM Holding AG Decreases Holdings in Lam Research Corporation $LRCX - MarketBeat
SteelPeak Wealth LLC Trims Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Stock Soars Amid Bullish Price Target Revisions - StocksToTrade
Lam Research Price Target Increases to $200 Amid AI Growth Optimism - StocksToTrade
Lam Research Corp. stock outperforms competitors on strong trading day - MSN
The Memory Market Is Going to Boom in 2026: 1 Top Stock to Buy Hand Over Fist Before It Skyrockets (Hint: It's Not Micron) - Finviz
Insights Into Lrcx Stock Market Trends And Investment Strategies Lam Research Corp Split History Scan - shababeek.org
Lam Research Corporation (LRCX) is Benefitting from Cyclical Demand - MSN
Lam Research (LRCX) Stock Surges to Record High After Citi, Cowen PraiseNews and Statistics - IndexBox
Why Is Lam Research (LRCX) Stock Rocketing Higher Today - Finviz
Lam Research (NASDAQ:LRCX) Sets New 1-Year HighHere's Why - MarketBeat
Lam Research Corp (LRCX)'s Winning Formula: Financial Metrics an - GuruFocus
Lam Research stock hits all-time high at 179.97 USD By Investing.com - Investing.com South Africa
Lam Research stock hits all-time high at 179.97 USD - Investing.com
Generali Asset Management SPA SGR Has $17.50 Million Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Stock Holdings Boosted by Allspring Global Investments Holdings LLC - MarketBeat
Braun Stacey Associates Inc. Cuts Stake in Lam Research Corporation $LRCX - MarketBeat
JB Capital LLC Has $310,000 Stake in Lam Research Corporation $LRCX - MarketBeat
Wall Street Bullish on Lam Research Corporation (LRCX), Here’s What You Need to Know - Insider Monkey
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):